Inspire Medical Systems, Inc. (NYSE: INSP) Faces Legal Challenges Amidst Growth Prospects

Core Insights - Inspire Medical Systems, Inc. specializes in innovative medical solutions for sleep apnea treatments, particularly through its Inspire therapy device, which serves as an alternative to CPAP machines [1] - Piper Sandler has set a price target of $165 for INSP, indicating a potential upside of 20.61% from the current trading price of $136.81 [1][6] Legal Issues - Inspire Medical is currently facing a class action lawsuit led by the Schall Law Firm, alleging violations of the Securities Exchange Act of 1934 related to securities fraud [2][5] - The lawsuit targets investors who purchased INSP securities between August 6, 2024, and August 4, 2025, with affected shareholders encouraged to contact the law firm by January 5, 2026 [3] Stock Performance - As of the latest update, INSP's stock price is $136.81, reflecting a decrease of 2.30% or $3.22, with trading fluctuations between $136.61 and $142.26 [4] - Over the past year, INSP has experienced significant volatility, with a high of $216.01 and a low of $70.77, and currently holds a market capitalization of approximately $4.05 billion [4][6]